Carson Wealth (CWM LLC)’s VanEck Biotech ETF BBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$42.3K Hold
225
﹤0.01% 3929
2025
Q4
$43K Hold
225
﹤0.01% 3705
2025
Q3
$37K Hold
225
﹤0.01% 3746
2025
Q2
$34K Hold
225
﹤0.01% 3545
2025
Q1
$35K Hold
225
﹤0.01% 3253
2024
Q4
$35K Hold
225
﹤0.01% 3045
2024
Q3
$40K Sell
225
-189
-46% -$33.5K ﹤0.01% 2862
2024
Q2
$70K Buy
414
+8
+2% +$1.31K ﹤0.01% 2224
2024
Q1
$67K Hold
406
﹤0.01% 2112
2023
Q4
$67K Buy
406
+6
+2% +$924 ﹤0.01% 2002
2023
Q3
$62K Buy
400
+13
+3% +$2.08K ﹤0.01% 1933
2023
Q2
$60K Buy
387
+104
+37% +$16.6K ﹤0.01% 1853
2023
Q1
$46K Buy
+283
New +$45.8K ﹤0.01% 1914
2022
Q2
Sell
-120
Closed -$19K 3771
2022
Q1
$19K Hold
120
﹤0.01% 2099
2021
Q4
$23K Buy
+120
New +$23.1K ﹤0.01% 1908
2021
Q2
$24K Hold
120
﹤0.01% 1700
2021
Q1
$24K Hold
120
﹤0.01% 1700
2020
Q4
$24K Hold
120
﹤0.01% 1700
2020
Q3
$24K Hold
120
﹤0.01% 1700
2020
Q2
$24K Hold
120
﹤0.01% 1700
2020
Q1
$24K Hold
120
﹤0.01% 1700
2019
Q4
$24K Hold
120
﹤0.01% 1700
2019
Q3
$24K Hold
120
﹤0.01% 1700
2019
Q2
$24K Hold
120
﹤0.01% 1700
2019
Q1
$24K Buy
+120
New +$15.2K ﹤0.01% 1700

Other funds holding BBH

Carson Wealth (CWM LLC)'s BBH Position: Q1 2026 in Review

Carson Wealth (CWM LLC) held its VanEck Biotech ETF (BBH) position steady in Q1 2026 at 225 shares worth $42.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3929.

Carson Wealth (CWM LLC) first reported a position in BBH in Q1 2019 and has held it in 25 quarters since. The position peaked at $70K in Q2 2024. 112 funds tracked by Wall St. Rank hold BBH as of Q1 2026.

  • Carson Wealth (CWM LLC) held 225 shares of VanEck Biotech ETF worth $42.3K as of Q1 2026.
  • Carson Wealth (CWM LLC) left its VanEck Biotech ETF share count unchanged in Q1 2026.
  • VanEck Biotech ETF made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #3929 holding.
  • Carson Wealth (CWM LLC) first reported a position in VanEck Biotech ETF in Q1 2019 and has held it in 25 quarters since.
  • Carson Wealth (CWM LLC)'s VanEck Biotech ETF position peaked at $70K in Q2 2024.
  • 112 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.